STRESSEconomicGlobal
U.S. demand for Novo Nordisk’s weight loss drugs is so huge that the Danish central bank just doubled the nation’s entire growth forecast
Published:
News summary
"The growth is mainly due to Novo’s sales and production in the U.S. market at the beginning of this year.".
- Importance
- Low · 23/100
- Impact direction
- Uncertain